92 STAT. 3582
PUBLIC LAW 95-626—NOV. 10, 1978 nosis and treatment, or follow-up for compliance with treatment of causative conditions in asymptomatic individuals. "(3) For purposes of subsection (d)(2), the term 'State and local expenditures for preventive health services' means expenditures by State and local public health authorities for preventive health services but excludes expenditures by such authorities— "(A) specifically required by Federal statutory law as a condition to the receipt of Federal financial assistance, or "(B) for operating inpatient care facilities or construction. "(4) For purposes of subsection (d), populations shall be determined on the basis of the latest figures available from the Department of Commerce. "(k)(1) For the purpose of making payments under grants under subsection (a) to assist States in meeting the costs of planning and developing programs described in such subsection, there are authorized to be appropriated $20,000,000 for the fiscal year ending September 30, 1980. "(2) For the purpose of making payments under grants under subsection (a) to assist States in meeting the costs of providing the programs described in such subsection, there are authorized to be appropriated $60,000,000 for the fiscal year ending September 30, 1981, and $75,000,000 for the fiscal year ending September 30, 1982. "(3) Not less than 20 per centum of the total amount of grants received by a State under subsection (a) for providing a program described in such subsection shall be obligated by the State for operating the health communications component of such program. No funds appropriated under this paragraph shall be used (A) to assist States in meeting the costs of traditional law enforcement activities (including the prevention of homicide) as defined in regulations of the Secretary, or (B) for construction.".
Appropriation authorization.
•B«r-
- ^" '
PROJECTS AND PROGRAMS FOR THE PREVENTION AND CONTROL OF VENEREAL DISEASE
42 USC 247c note.
i 1
t;;!(!.-
'
SEC. 204. (a) The Congress finds and declares that—
(1) the number of reported cases of venereal disease persists in epidemic proportions in the United States;
(2) the number of persons affected by venereal disease and reported to public health authorities is only a fraction of those actually affected; (3) the incidence of venereal disease continues to be particularly high among American youth, ages fifteen to twenty-nine, and among populations in metropolitan areas; (4) venereal disease accounts for severe permanent disabilities and sometimes death in newborns and causes reproductive dysfunction in women of childbearing age; (5) it is conservatively estimated that the public cost of health care for persons suffering from complications of venereal disease exceeds one-half billion dollars annually; (6) the number of trained Federal venereal disease prevention and control personnel has fallen to a dangerously inadequate level; (7) no vaccine for syphilis, gonorrhea, or any other venereal disease has yet been developed, nor does a blood test for the detection of asymptomatic gonorrhea in women exist, nor are safe and effective therapeutic agents available for some other venereal diseases;
�
